Latest stories on OPY
Renibus Therapeutics Announces Participation at the Oppenheimer Private Life Sciences Company Showcase
PR Newswire55 · neutralgeneral
McDonald’s price target lowered to $295 from $325 at Oppenheimer
The Fly38 · neutralanalyst
Oppenheimer reiterates Ligand Pharma stock rating on AvenCell deal
Investing.com Analyst Ratings56 · neutralanalyst
Knife River price target lowered to $80 from $90 at Oppenheimer
The Fly34 · bearishanalyst
Oppenheimer raises Dynatrace price target to $71, adds to top picks
The Fly61 · neutralanalyst
Oppenheimer reiterates Corteva stock rating amid spinoff focus
Investing.com Analyst Ratings56 · neutralanalyst
Kodiak AI management to meet with Oppenheimer
The Fly55 · neutralgeneral
Everus Construction management to meet with Oppenheimer
The Fly55 · neutralgeneral
SiriusPoint management to meet virtually with Oppenheimer
The Fly50 · neutralgeneral
Euronet management to meet virtually with Oppenheimer
The Fly50 · neutralgeneral
MedinCell initiated with an Outperform at Oppenheimer
The Fly61 · neutralanalyst
Coherus Oncology retains Oppenheimer to market legacy biosimilar assets
The Fly55 · neutralgeneral
Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets
GlobeNewswire56 · neutralgeneral
Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets
Business Insider55 · neutralgeneral
Oppenheimer initiates Inova Technology stock rating at Outperform
Investing.com Analyst Ratings61 · neutralanalyst
Innoviva assumed with an Outperform at Oppenheimer
The Fly67 · bullishanalyst
Oppenheimer initiates Viatris stock with outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
Oppenheimer initiates Collegium Pharmaceutical stock at Outperform
Investing.com Analyst Ratings61 · neutralanalyst
Oppenheimer initiates Vanda Pharmaceuticals stock with outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
Oppenheimer initiates ANI Pharmaceuticals stock with Perform rating
Investing.com Analyst Ratings50 · neutralanalyst
Oppenheimer initiates Amneal Pharmaceuticals stock with outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
Oppenheimer initiates CorMedix stock coverage with outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
Oppenheimer initiates Pacira stock with outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
Amneal Pharmaceuticals initiated with an Outperform at Oppenheimer
The Fly63 · neutralanalyst
Viatris initiated with an Outperform at Oppenheimer
The Fly61 · neutralanalyst